PDCD1 and neoplasm: While PD-1/PD-L1 pathway is pivotal to sustain an equilibrium between autoimmunity and peripheral tolerance, it impairs tumor immunity when employed by cancer cells promoting immune suppression and immune surveillance escape (34).